vs
STANDARD BIOTOOLS INC.（LAB）与RGC RESOURCES INC（RGCO）财务数据对比。点击上方公司名可切换其他公司
RGC RESOURCES INC的季度营收约是STANDARD BIOTOOLS INC.的1.6倍（$30.6M vs $19.6M），RGC RESOURCES INC净利率更高（16.0% vs -177.4%，领先193.4%），RGC RESOURCES INC同比增速更快（13.9% vs -11.5%），RGC RESOURCES INC自由现金流更多（$-4.6M vs $-23.1M），过去两年RGC RESOURCES INC的营收复合增速更高（-0.4% vs -12.2%）
Standard BioTools（原Fluidigm公司）是一家美国生命科学工具企业，主营流式细胞术与组织成像分析用质谱流式系统，以及配套的检测试剂盒与试剂，同时供应自动化基因组分析仪器、各类微流控芯片（又称集成流体电路）及配套试剂耗材，全系列产品及应用场景均可提供定制检测方案与相关服务。
伊鲁卡资源是一家澳大利亚资源企业，专注于砂矿勘探、项目开发、运营与营销。该公司在1998年7月由西澳砂矿公司与RGC有限公司的钛矿物业务合并而成，1999年正式定名为伊鲁卡资源有限公司。它是全球主要的锆石、二氧化钛衍生金红石及合成金红石生产商，在澳大利亚拥有运营业务，也曾在美国等地区开展业务。
LAB vs RGCO — 直观对比
损益表 — Q3 FY2025 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $19.6M | $30.6M |
| 净利润 | $-34.7M | $4.9M |
| 毛利率 | 48.5% | — |
| 营业利润率 | -168.5% | 21.4% |
| 净利率 | -177.4% | 16.0% |
| 营收同比 | -11.5% | 13.9% |
| 净利润同比 | -28.8% | -7.3% |
| 每股收益（稀释后） | $-0.09 | $0.47 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
| Q4 25 | — | $30.6M | ||
| Q3 25 | $19.6M | $14.0M | ||
| Q2 25 | $21.8M | $16.6M | ||
| Q1 25 | $40.8M | $36.5M | ||
| Q4 24 | — | $26.8M | ||
| Q3 24 | $22.1M | $12.8M | ||
| Q2 24 | $22.5M | $13.6M | ||
| Q1 24 | $45.5M | $30.8M |
| Q4 25 | — | $4.9M | ||
| Q3 25 | $-34.7M | $-204.3K | ||
| Q2 25 | $-33.5M | $538.4K | ||
| Q1 25 | $-26.0M | $7.7M | ||
| Q4 24 | — | $5.3M | ||
| Q3 24 | $-26.9M | $140.8K | ||
| Q2 24 | $-45.7M | $156.7K | ||
| Q1 24 | $-32.2M | $6.4M |
| Q4 25 | — | — | ||
| Q3 25 | 48.5% | — | ||
| Q2 25 | 48.8% | — | ||
| Q1 25 | 48.4% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 54.9% | — | ||
| Q2 24 | 46.1% | — | ||
| Q1 24 | 53.1% | — |
| Q4 25 | — | 21.4% | ||
| Q3 25 | -168.5% | -3.4% | ||
| Q2 25 | -118.1% | 7.2% | ||
| Q1 25 | -80.8% | 28.5% | ||
| Q4 24 | — | 27.3% | ||
| Q3 24 | -120.9% | 1.9% | ||
| Q2 24 | -134.5% | 11.5% | ||
| Q1 24 | -132.2% | 28.0% |
| Q4 25 | — | 16.0% | ||
| Q3 25 | -177.4% | -1.5% | ||
| Q2 25 | -153.7% | 3.2% | ||
| Q1 25 | -63.8% | 21.1% | ||
| Q4 24 | — | 19.6% | ||
| Q3 24 | -122.0% | 1.1% | ||
| Q2 24 | -203.3% | 1.2% | ||
| Q1 24 | -70.6% | 20.9% |
| Q4 25 | — | $0.47 | ||
| Q3 25 | $-0.09 | $-0.01 | ||
| Q2 25 | $-0.09 | $0.05 | ||
| Q1 25 | $-0.07 | $0.74 | ||
| Q4 24 | — | $0.51 | ||
| Q3 24 | $-0.07 | $0.01 | ||
| Q2 24 | $-0.12 | $0.02 | ||
| Q1 24 | $-0.27 | $0.63 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $129.4M | — |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $399.7M | $116.4M |
| 总资产 | $539.6M | $341.0M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
| Q4 25 | — | — | ||
| Q3 25 | $129.4M | — | ||
| Q2 25 | $158.6M | — | ||
| Q1 25 | $150.9M | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $210.6M | — | ||
| Q2 24 | $269.8M | — | ||
| Q1 24 | $287.1M | — |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $55.2M | — | ||
| Q2 24 | $55.1M | — | ||
| Q1 24 | $55.0M | — |
| Q4 25 | — | $116.4M | ||
| Q3 25 | $399.7M | $113.6M | ||
| Q2 25 | $424.5M | $116.3M | ||
| Q1 25 | $454.6M | $117.8M | ||
| Q4 24 | — | $111.8M | ||
| Q3 24 | $489.3M | $108.1M | ||
| Q2 24 | $510.3M | $108.8M | ||
| Q1 24 | $577.3M | $110.5M |
| Q4 25 | — | $341.0M | ||
| Q3 25 | $539.6M | $329.8M | ||
| Q2 25 | $557.0M | $324.8M | ||
| Q1 25 | $579.6M | $326.4M | ||
| Q4 24 | — | $335.2M | ||
| Q3 24 | $681.5M | $320.7M | ||
| Q2 24 | $708.7M | $314.2M | ||
| Q1 24 | $777.7M | $313.4M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 0.11× | — | ||
| Q2 24 | 0.11× | — | ||
| Q1 24 | 0.10× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-22.2M | $1.1M |
| 自由现金流经营现金流 - 资本支出 | $-23.1M | $-4.6M |
| 自由现金流率自由现金流/营收 | -118.1% | -14.9% |
| 资本支出强度资本支出/营收 | 4.5% | 18.5% |
| 现金转化率经营现金流/净利润 | — | 0.22× |
| 过去12个月自由现金流最近4个季度 | $-111.1M | — |
8季度趋势，按日历期对齐
| Q4 25 | — | $1.1M | ||
| Q3 25 | $-22.2M | $675.1K | ||
| Q2 25 | $-20.7M | $6.4M | ||
| Q1 25 | $-30.3M | $21.0M | ||
| Q4 24 | — | $827.2K | ||
| Q3 24 | $-27.9M | $377.4K | ||
| Q2 24 | $-39.0M | $5.9M | ||
| Q1 24 | $-62.5M | $11.8M |
| Q4 25 | — | $-4.6M | ||
| Q3 25 | $-23.1M | — | ||
| Q2 25 | $-22.6M | $1.4M | ||
| Q1 25 | $-35.3M | $16.1M | ||
| Q4 24 | — | $-4.9M | ||
| Q3 24 | $-30.1M | $-5.1M | ||
| Q2 24 | $-41.0M | $564.7K | ||
| Q1 24 | $-63.3M | $5.8M |
| Q4 25 | — | -14.9% | ||
| Q3 25 | -118.1% | — | ||
| Q2 25 | -103.6% | 8.4% | ||
| Q1 25 | -86.6% | 44.1% | ||
| Q4 24 | — | -18.3% | ||
| Q3 24 | -136.4% | -40.2% | ||
| Q2 24 | -182.2% | 4.2% | ||
| Q1 24 | -138.9% | 18.8% |
| Q4 25 | — | 18.5% | ||
| Q3 25 | 4.5% | — | ||
| Q2 25 | 8.7% | 30.4% | ||
| Q1 25 | 12.4% | 13.6% | ||
| Q4 24 | — | 21.4% | ||
| Q3 24 | 10.2% | 43.2% | ||
| Q2 24 | 8.6% | 39.0% | ||
| Q1 24 | 1.7% | 19.4% |
| Q4 25 | — | 0.22× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 11.96× | ||
| Q1 25 | — | 2.74× | ||
| Q4 24 | — | 0.16× | ||
| Q3 24 | — | 2.68× | ||
| Q2 24 | — | 37.36× | ||
| Q1 24 | — | 1.83× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
LAB
| Consumables | $8.7M | 45% |
| Services And Other Revenue | $5.8M | 29% |
| Instruments | $5.1M | 26% |
RGCO
暂无分部数据
